2023
DOI: 10.1016/j.jpha.2023.04.010
|View full text |Cite
|
Sign up to set email alerts
|

A robust luminescent assay for screening alkyladenine DNA glycosylase inhibitors to overcome DNA repair and temozolomide drug resistance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 36 publications
0
3
0
Order By: Relevance
“…Mitochondrial membrane potential evaluation was performed according to previous reports [ 21 , [23] , [24] , [25] ]. HeLa cells were cultured until they reached a fusion of 70 %, after which they were digested with trypsin and adjusted to a cell density of approximately 1 × 10 5 /mL with 10 % RPMI-1640 medium.…”
Section: Experimentalsmentioning
confidence: 99%
“…Mitochondrial membrane potential evaluation was performed according to previous reports [ 21 , [23] , [24] , [25] ]. HeLa cells were cultured until they reached a fusion of 70 %, after which they were digested with trypsin and adjusted to a cell density of approximately 1 × 10 5 /mL with 10 % RPMI-1640 medium.…”
Section: Experimentalsmentioning
confidence: 99%
“…To investigate whether the transcriptional upregulation of LIP is related to a specific DNA lesion type, the TMZ was selected to induce DNA lesions, which caused DNA damage primarily eliminated by the BER pathway. According to publications, over 80% of DNA damage induced TMZ consists of N7-methyl guanine and N3-methyl adenine, both repaired through the BER pathway [ 23 , 24 ]. Remarkably, treatment with 1 mM TMZ resulted in a significant upregulation of LIP in HeLa cells ( Fig.…”
Section: Resultsmentioning
confidence: 99%
“…High nuclear MPG levels (associated with epigenetic silencing of HTATIP2, a negative regulator of cytoplasmicnuclear translocation) appear to be associated with resistance to methylating agents [154]. Drug screening revealed Sunitinib to be effective in inhibiting MPG, which restored TMZ sensitivity [155], suggesting repurposing the drug in glioma therapy. Overall, in MGMT proficient-tumors, imbalances in BER may contribute to drug resistance as well as sensitivity.…”
Section: Why Are Glioblastomas Refractory To Alkylating Agent-based T...mentioning
confidence: 99%